TRF2 Antikörper
-
- Target Alle TRF2 (TERF2) Antikörper anzeigen
- TRF2 (TERF2) (Telomeric Repeat Binding Factor 2 (TERF2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TRF2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human TERF2
- Isotyp
- IgG
- Top Product
- Discover our top product TERF2 Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Handhabung
- Avoid freeze / thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- TRF2 (TERF2) (Telomeric Repeat Binding Factor 2 (TERF2))
- Andere Bezeichnung
- TERF2 (TERF2 Produkte)
- Synonyme
- TERF2 antikoerper, TRBF2 antikoerper, TRF2 antikoerper, trf2 antikoerper, telomeric repeat binding factor 2 antikoerper, telomeric repeat binding factor 2 L homeolog antikoerper, TERF2 antikoerper, Terf2 antikoerper, terf2.L antikoerper
- Hintergrund
- This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres. While having similar telomere binding activity and domain organization, TERF2 differs from TERF1 in that its N terminus is basic rather than acidic.
- NCBI Accession
- NP_005643
- Pathways
- Zellzyklus, Telomere Maintenance
-